WebCancer Letters is an international journal that considers full-length articles and Mini Reviews in the broad area of basic and translational oncology. Additionally, Special … WebCANCER LETTERS Metrics 2.24 SJR 1.346 SNIP 161 H-Index 6.5 CiteScore General Information Indexing: Science Citation Index Frequency: Biweekly Open access: No Acceptance rate: About 52.27% Official Website: CANCER LETTERS Area of Publication: NETHERLANDS Time for acceptance: About 2.7 month (s) Similar Journals CA-A …
Mini Reviews - Cancer Letters ScienceDirect.com by Elsevier
Web2 days ago · Now, a judge in California has taken an entirely different approach, opening the door to what may be the first trial concerning the blockbuster drug and whether it causes cancer. A few weeks ago ... WebApr 12, 2024 · WALTHAM, Mass.--(BUSINESS WIRE)-- Naveris, Inc., a leader in molecular diagnostics for viral cancers, today announced the launch of the DART 2.0 prospective clinical trial (NCT05541016) by Mayo Clinic.The DART 2.0 trial will evaluate the ability of NavDx, Naveris’ flagship blood test for tumor tissue modified viral (TTMV)-HPV DNA, to … blakemans tree services
Editorial Board - Cancer Letters - Journal - Elsevier
WebImpact Factor is the most common scientometric index, which is defined by the number of citations of papers in two preceding years divided by the number of papers published in … WebCancer Letters Supports 16.1 CiteScore 9.756 Impact Factor Articles & Issues Articles in press Special issues and article collections Linked datasets RSS About Publish Order journal Submit your article Guide for authors Volume 526 Pages 1-366 (1 February 2024) Download full issue Previous vol/issue Next vol/issue WebMay 27, 2024 · Cancer Letters IS is increased by a factor of 1.02 and approximate percentage change is 12.99% when compared to preceding year 2024, which shows a … fragrance shop west bromwich